An Open-label, Randomized, Four-way Crossover Single Oral Dose Study Comparing the Pharmacokinetics of Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Balcinrenone (Primary)
- Indications Cardiovascular disorders; Heart failure
- Focus Pharmacokinetics
- Sponsors AstraZeneca
Most Recent Events
- 06 May 2019 Status changed from active, no longer recruiting to completed.
- 19 Mar 2019 Planned End Date changed from 19 Apr 2019 to 4 Apr 2019.
- 19 Mar 2019 Planned primary completion date changed from 19 Apr 2019 to 4 Apr 2019.